Your browser doesn't support javascript.
loading
Advances in Engineering Cells for Cancer Immunotherapy.
Xu, Xiao; Li, Teng; Shen, Shiyang; Wang, Jinqiang; Abdou, Peter; Gu, Zhen; Mo, Ran.
Afiliação
  • Xu X; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing 210009, China.
  • Li T; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing 210009, China.
  • Shen S; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing 210009, China.
  • Wang J; Department of Bioengineering, University of California, Los Angeles, CA 90095, USA.
  • Abdou P; Jonsson Comprehensive Cancer Center, California NanoSystems Institute, and Center for Minimally Invasive Therapeutics, University of California, Los Angeles, CA 90095, USA.
  • Gu Z; Department of Bioengineering, University of California, Los Angeles, CA 90095, USA.
  • Mo R; Jonsson Comprehensive Cancer Center, California NanoSystems Institute, and Center for Minimally Invasive Therapeutics, University of California, Los Angeles, CA 90095, USA.
Theranostics ; 9(25): 7889-7905, 2019.
Article em En | MEDLINE | ID: mdl-31695806

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article